Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility is currently unavailable.

OX40 engagement depletes intratumoral Tregs via activating Fc?Rs, leading to antitumor efficacy.

OX40 engagement depletes intratumoral Tregs via activating Fc?Rs, leading to antitumor efficacy. Immunol Cell Biol. 2014 Jul; 92(6):475-80.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.